Concepedia

Mathew Williams

MW

Statistics

Publications

28

Citations

2.8K

H-Index

21

Active since

2004

Affiliations

Medical Research Institute of New Zealand(Current)

University of Otago

Capital and Coast District Health Board

University of Southampton

Pacific Radiology (New Zealand)

Mathew Williams is an author at Medical Research Institute of New Zealand specializing in pulmonology, pulmonary function testing, and pharmacy.

Publications per year

2004–2022

28

Publications

28

Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma

Richard Beasley, Mark Holliday, Helen K. Reddel et al. · New England Journal of Medicine · 2019 · 458 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?

Justin Travers, S. Marsh, Mathew Williams et al. · Thorax · 2006 · 307 citations · Full text

Medicine, Internal Medicine, Epidemiology +6

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

Jo Hardy, Christina Baggott, James Fingleton et al. · The Lancet · 2019 · 276 citations

Pharmacy, Internal Medicine, Pharmacotherapy +9

Distinct clinical phenotypes of airways disease defined by cluster analysis

Mark Weatherall, Justin Travers, P. M. Shirtcliffe et al. · European Respiratory Journal · 2009 · 245 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Proportional classifications of COPD phenotypes

Suzanne Marsh, Justin Travers, Mark Weatherall et al. · Thorax · 2008 · 242 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

1–5 of 28